Matches in SemOpenAlex for { <https://semopenalex.org/work/W137681149> ?p ?o ?g. }
Showing items 1 to 39 of
39
with 100 items per page.
- W137681149 startingPage "417" @default.
- W137681149 created "2016-06-24" @default.
- W137681149 creator A5009028099 @default.
- W137681149 creator A5029358901 @default.
- W137681149 creator A5030475213 @default.
- W137681149 creator A5032296316 @default.
- W137681149 creator A5032304728 @default.
- W137681149 creator A5043577926 @default.
- W137681149 creator A5051529138 @default.
- W137681149 creator A5087422571 @default.
- W137681149 creator A5088180345 @default.
- W137681149 date "2010-02-01" @default.
- W137681149 modified "2023-09-24" @default.
- W137681149 title "P1-205 卵巣漿液性嚢胞腺癌におけるBAF57を分子標的とした治療の可能性についての検討(Group25 卵巣腫瘍1,一般演題,第62回日本産科婦人科学会学術講演会)" @default.
- W137681149 hasPublicationYear "2010" @default.
- W137681149 type Work @default.
- W137681149 sameAs 137681149 @default.
- W137681149 citedByCount "0" @default.
- W137681149 crossrefType "journal-article" @default.
- W137681149 hasAuthorship W137681149A5009028099 @default.
- W137681149 hasAuthorship W137681149A5029358901 @default.
- W137681149 hasAuthorship W137681149A5030475213 @default.
- W137681149 hasAuthorship W137681149A5032296316 @default.
- W137681149 hasAuthorship W137681149A5032304728 @default.
- W137681149 hasAuthorship W137681149A5043577926 @default.
- W137681149 hasAuthorship W137681149A5051529138 @default.
- W137681149 hasAuthorship W137681149A5087422571 @default.
- W137681149 hasAuthorship W137681149A5088180345 @default.
- W137681149 hasConcept C41008148 @default.
- W137681149 hasConceptScore W137681149C41008148 @default.
- W137681149 hasIssue "2" @default.
- W137681149 hasLocation W1376811491 @default.
- W137681149 hasOpenAccess W137681149 @default.
- W137681149 hasPrimaryLocation W1376811491 @default.
- W137681149 hasVolume "62" @default.
- W137681149 isParatext "false" @default.
- W137681149 isRetracted "false" @default.
- W137681149 magId "137681149" @default.
- W137681149 workType "article" @default.